
With modern labs managing more data than ever before, maintaining GxP compliance across documentation, data integrity, training records, and audit trails is a moving target.
That’s especially the case when your lab still relies on spreadsheets, paper logs, or a legacy system that fights you at every turn.
This guide breaks down the specific best practices FDA inspectors look for in laboratory settings and shows you exactly how to operationalize each one. You'll walk away with a concrete framework you can implement this quarter, not a glossary of acronyms you already know.
GxP standards draw on a wide range of global standards and are intended to ensure that products produced by labs are safe, meet their intended use, and follow quality processes throughout manufacturing.
“GxP” is a catch-all term; you can think of GxP as “Good <fill in an industry> Practice,” which lays out a series of standards and guidelines to follow.
GxP itself isn’t a firm requirement; however, adherence to GxP demonstrates that lab results are auditable, processes are documented, data is managed correctly, and best practices are followed in the lab. GxP guidelines also fall under regulations and standards that may be required.
Within GxP, there are several specific guidelines, such as:
While there is some variance across these, the core tenets of GxP cover the following best practices:
Next, we’ll share some common lab scenarios and what you can expect when meeting GxP standards.
As a whole, GxP covers how labs manage data, oversee products, and maintain quality. But there is variance between industries on what GxP means, which is worth exploring in detail:
GLP governs non-clinical safety studies; for example, the toxicology, pharmacology, and environmental testing data submitted to regulators to support product approvals.
In the United States, GLP is codified in 21 CFR Part 58. Internationally, the OECD Principles of Good Laboratory Practice set the framework most countries follow. If your lab generates data that ends up in an IND, NDA, or pesticide registration submission, you're operating under GLP. Concrete obligations include study director designation, archived raw data with defined retention periods, and SOPs covering every method you run.
GMP, specifically 21 CFR Parts 210 and 211 for drug products in the United States, governs the manufacture, processing, and holding of pharmaceutical products.
Labs feel GMP most directly through QC testing: release testing of finished drug products, stability programs, raw material identification, and environmental monitoring of cleanrooms. A QC lab supporting GMP manufacturing isn't just "following GMP"; it's a regulated unit whose data becomes part of the batch record.
GCP applies to clinical trial conduct, and labs touch it through bioanalytical work, central lab testing, and biomarker assays performed on study samples.
The relevant frameworks include ICH E6(R3) and 21 CFR Parts 50, 54, 56, and 312, which cover informed consent, financial disclosure, IRBs, and IND requirements, respectively. Specimen chain-of-custody, blinding controls, and method validation under GCLP are where lab teams typically interact with this framework.
A common mistake is for labs to assume only one of these applies to them. In reality, there may be crossover between them for your lab, meaning your quality management systems need to flex across standards rather than simply meeting one.
Data integrity is the most frequently cited deficiency in FDA warning letters to laboratories.
It's also the area where well-intentioned labs slip without realizing it: not through fraud, but through workflows that quietly violate ALCOA+ every day.
ALCOA+ is the framework regulators use to evaluate whether your data can be trusted. It originated with the FDA in the 1990s and was extended by MHRA and PIC/S into ALCOA+, which adds Complete, Consistent, Enduring, and Available.
You’re probably spotting a trend here: meeting the above framework with manual data transcription methods is incredibly painful at best.
That’s why modern labs are turning to software platforms like a LIMS to manage their data and compliance at scale.
Here's how a modern, configurable LIMS turns GxP from a manual burden into a built-in feature of your lab:
Without a LIMS, it’s up to you to manage records for every single action: every result, every failed test, every approval, along with verification and timestamps.
A LIMS does this automatically. Every instrument reading and test result is logged with appropriate metadata, ensuring that you can retrieve records as needed and defend them to an inspector. With a LIMS, the ALCOA+ criteria above stop being a checklist that analysts have to remember and become a built-in function of your systems.
Where do your SOPs live now?
With a LIMS, SOPs are stored in a single controlled location with version locking, mandatory acknowledgment workflows, and direct linkage to the methods and training records that depend on them. For example, with QBench’s built-in QMS, you can store documents and use version control and document approvers to ensure only the most recently approved version is accessible to relevant staff.
A LIMS ensures you’re alerted to abnormalities or out-of-spec results instantly, and not hours – or days – after the fact.
A LIMS gives you real-time visibility into open deviations, overdue CAPAs, calibration status, training currency, and environmental monitoring excursions, which means an auditor's questions can be answered in minutes.
Many LIMS (QBench included) also offer built-in support for the electronic signature requirements for 21 CFR Part 11. QBench offers electronic signatures with two-factor authentication, validated user access controls, secure timestamped audit trails, and documented system validation.
While you technically can manage all of the above with paper-based systems or a legacy LIMS, the ease of use and speed offered by a cloud-based LIMS mean your staff can spend more time on the work at hand and less time chasing down records.
Once you begin your search for the right LIMS, you’ll find substantial differences among platforms. We recommend you consider the following and ask these questions when evaluating vendors:
There is a wide variety of software available to aid in managing GxP, so bear the above in mind when guiding your vendor evaluations.
Once you’ve decided to invest in a LIMS, it’s time to make sure you invest in the right LIMS.
There’s one small problem: which vendor(s) will you review? With so many vendors to pick from and features to consider, we created a LIMS buyer’s guide to help you make the right choice for your lab. In this guide, you will learn the following:
And more!
Fill out the form below to get your free guide and take the first step toward automating your lab today.